<SEC-DOCUMENT>0001973379-24-000086.txt : 20240304 <SEC-HEADER>0001973379-24-000086.hdr.sgml : 20240304 <ACCEPTANCE-DATETIME>20240304145421 ACCESSION NUMBER: 0001973379-24-000086 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ascendis Pharma A/S CENTRAL INDEX KEY: 0001612042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36815 FILM NUMBER: 24714544 BUSINESS ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 BUSINESS PHONE: 45 70 22 22 44 MAIL ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG CENTRAL INDEX KEY: 0001965755 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ASCENDIS PHARMA A/S STREET 2: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 </SEC-HEADER> <DOCUMENT> <TYPE>144 <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> <XML> <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common"> <headerData> <submissionType>144</submissionType> <filerInfo> <filer> <filerCredentials> <cik>0001965755</cik> <ccc>XXXXXXXX</ccc> </filerCredentials> </filer> <liveTestFlag>LIVE</liveTestFlag> </filerInfo> </headerData> <formData> <issuerInfo> <issuerCik>0001612042</issuerCik> <issuerName>Ascendis Pharma A/S</issuerName> <secFileNumber>001-36815</secFileNumber> <issuerAddress> <com:street1>TUBORG BOULEVARD 12</com:street1> <com:city>HELLERUP</com:city> <com:stateOrCountry>G7</com:stateOrCountry> <com:zipCode>DK-2900</com:zipCode> </issuerAddress> <issuerContactPhone>45 70 22 22 44</issuerContactPhone> <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold> <relationshipsToIssuer> <relationshipToIssuer>Officer</relationshipToIssuer> </relationshipsToIssuer> </issuerInfo> <securitiesInformation> <securitiesClassTitle>Ordinary Shares</securitiesClassTitle> <brokerOrMarketmakerDetails> <name>Citigroup Global Markets Inc.</name> <address> <com:street1>390 Greenwich Street</com:street1> <com:city>New York</com:city> <com:stateOrCountry>NY</com:stateOrCountry> <com:zipCode>10013</com:zipCode> </address> </brokerOrMarketmakerDetails> <noOfUnitsSold>3892</noOfUnitsSold> <aggregateMarketValue>583800.00</aggregateMarketValue> <noOfUnitsOutstanding>57707439</noOfUnitsOutstanding> <approxSaleDate>03/01/2024</approxSaleDate> <securitiesExchangeName>NASDAQ</securitiesExchangeName> </securitiesInformation> <securitiesToBeSold> <securitiesClassTitle>Ordinary Shares</securitiesClassTitle> <acquiredDate>03/01/2024</acquiredDate> <natureOfAcquisitionTransaction>Restricted Stock Vesting</natureOfAcquisitionTransaction> <nameOfPersonfromWhomAcquired>Ascendis Pharma A/S</nameOfPersonfromWhomAcquired> <isGiftTransaction>N</isGiftTransaction> <amountOfSecuritiesAcquired>6900</amountOfSecuritiesAcquired> <paymentDate>03/01/2024</paymentDate> <natureOfPayment>Services Rendered</natureOfPayment> </securitiesToBeSold> <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months> <securitiesSoldInPast3Months> <sellerDetails> <name>PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG</name> <address> <com:street1>c/o Tuborg Blvd 12</com:street1> <com:city>Hellerup</com:city> <com:stateOrCountry>G7</com:stateOrCountry> <com:zipCode>DK-2900</com:zipCode> </address> </sellerDetails> <securitiesClassTitle>Ordinary Shares</securitiesClassTitle> <saleDate>02/27/2024</saleDate> <amountOfSecuritiesSold>5625</amountOfSecuritiesSold> <grossProceeds>866545.27</grossProceeds> </securitiesSoldInPast3Months> <remarks>The sales were completed according to 10B5-1 plans entered into in September 2023, for the sale of shares in connection to RSUs and PSUs vesting.</remarks> <noticeSignature> <noticeDate>03/04/2024</noticeDate> <signature>Conformed Signature on File</signature> </noticeSignature> </formData> </edgarSubmission> </XML> </TEXT> </DOCUMENT> </SEC-DOCUMENT>